Infektiologie und Tropenmedizin - Neue Entwicklungen 2006

Literatur

• 1 Ahmed A, Li J, Shiloach Y, Robbins J B, Szu S C. Safety and immunogenicity of E. coli O157 O-specific polysaccharide conjugate vaccine in 2 - 5-year-old children.  J Infect Dis. 2006;  193 515-521
• 2 Bertolotti L, Tomassone L, Tramuta C. et al . Borrelia lusitaniae and spotted fever group rickettsiae in Ixodes ricinus in Tuscany, central Italy.  J Med Entomol. 2006;  43 159-165
• 3 Brooker S, Clements A C, Bundy D A. Global epidemiology, ecology and control of soil-transmitted helminth infections.  Adv Parasitol. 2006;  62 221-261
• 4 Charrel R N, Gallian P, Navarro-Mari J M. et al . Emergence of Toscana virus in Europe.  Emerg Infect Dis. 2005;  11 1657-1663
• 5 Cinco M, Luzzati R, Mascioli M. et al . Serological evidence of Rickettsia infections in forestry rangers in north-eastern Italy.  Clin Microbiol Infect. 2006;  12 493-495
• 6 Clarke S R, Brummell K J, Horsburgh M J. et al . Identification of in-vivo expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.  J Infect Dis. 2006;  193 1098-1108
• 7 Clifford G M, Gallus S, Herrero R. et al . Worldwide distribution of human papilloma virus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.  Lancet. 2005;  366 991-998
• 8 Croft S L, Sundar S, Fairlamb A H. Drug resistance in leishmaniasis.  Clin Microbiol Rev. 2006;  19 111-126
• 9 da Franca I, Santos L, Mesquita T. et al . Lyme borreliosis in Portugal caused by Borrelia lusitaniae? Clinical report on the first patient with a positive skin isolate.  Wien Klin Wochenschr. 2005;  117 429-432
• 10 Dondorp A, Nosten F, Stepniewska K, Day N, White N. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group . Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.  Lancet. 2005;  366 717-725
• 11 DTG .Leitlinien zur Diagnostik und Therapie der Malaria, der Kala-Azar, des Amöbenleberabszesses der Deutschen Gesellschaft für Tropenmedizin und Internationale Gesundheit,. aktualisiert 11/2005: http://leitlinien.net/
• 12 Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.  Clin Microbiol Infect. 2006;  12 551-544
• 13 Farcas G A, Soeller R, Zhong K, Zahirieh A, Kain K C. Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers.  Clin Infect Dis. 2006;  42 622-627
• 14 Freedman D O, Weld L H, Kozarsky P E. et al . GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers.  N Engl J Med. 2006;  354 119-130
• 15 Frimmel S, Löbermann M, Buxton B, Reisinger E C. Abducens nerve palsy following a tick bite.  Int J Med Microbiol. 2006;  296 (Suppl 1) 304-305
• 16 Geisbert T W, Jones S, Fritz E A. et al . Development of a new vaccine for the prevention of Lassa fever.  PLoS Med. 2005;  2 e183
• 17 Glass R I, Parashar D U. The promise of New Rotavirus Vaccines.  N Engl J Med. 2006;  354 75-77
• 18 Hemmer C, Littmann M, Löbermann M, Lafrenz M, Böttcher T, Reisinger E C. Tickborne meningoencephalitis, first case after 19 years in northeastern Germany.  Emerg Infect Dis. 2005;  11 633-634
• 19 Hoerauf A. New strategies to combat filariasis.  Expert Rev Anti Infect. 2006;  4 211-222
• 20 Keine Autorenangabe . Enrollment halted in the SMART study.  AIDS Clin Care. 2006;  18 15
• 21 Kihara M, Carter J A, Newton C R. The effect of Plasmodium falciparum on cognition: a systematic review.  Trop Med Int Health. 2006;  11 386-397
• 22 Koopmans N G, Kwee W S, Grave W, Stals F S. Severe diarrhoea with invasive intestinal spirochaetosis.  Ned Tijdschr Geneeskd. 2005;  149 2873-2876
• 23 Kublin J G, Steketee R W. HIV infection and malaria - understanding the interactions.  J Infect Dis. 2006;  193 1-3
• 24 Kyaw M H, Lynfield R, Schaffner W. et al . Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant streptococcus pneumoniae.  N Eng J Med. 2006;  354 1455-1463
• 25 Lalezari J, Thompson M, Kumar P. et al . Antiviral activity and safety of 873 140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults.  AIDS. 2005;  19 1443-1448
• 26 Lammie P J. The promise of Wolbachia-targeted chemotherapy as a public health intervention for lymphatic filariasis and onchocerciasis.  Clin Infect Dis. 2006;  42 1090-1092
• 27 Lehrman G, Hogue I B, Palmer S. et al . Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.  Lancet. 2005;  366 549-555
• 28 Loebermann M, Fingerle V, Lademann M, Fritzsche C, Reisinger E C. Borrelia burgdorferi and Anaplasma phagocytophilum co-infection.  Emerg Infect Dis. 2006;  12 765
• 29 Madani T A. Alkhumra virus infection, a new viral hemorrhagic fever in Saudi Arabia.  J Infect. 2005;  51 91-97
• 30 Madhi S A, Ludewick H, Kuwanda L. et al . Pneumococcal coinfection with human metapneumovirus.  J Infect Dis. 2006;  193 1236-1243
• 31 Maitland K, Nadel S, Pollard A J, Williams T N, Newton C R, Levin M. Management of severe malaria in children: proposed guidelines for the United Kingdom.  BMJ. 2005;  331 337-343
• 32 Marin M, Nguyen H Q, Langidrik J R. et al . Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.  Clin Infect Dis. 2006;  42 315-319
• 33 Martin D, Jacobson J, Schurmann D. et al .PA-457, the first-in-class maturation inhibitor, exhibits antiviral activity following a single oral dose in HIV-1-infected patients. Abstract 159, 12th CROI, Boston 2005
• 34 McNicholl I R, McNicholl J J. On the horizon: promising investigational antiretroviral agents.  Curr Pharm Des. 2006;  12 1091-1103
• 35 Ndayimirije N, Kindhauser M K. Marburg hemorrhagic fever in Angola-fighting fear and a lethal pathogen.  N Engl J Med. 2005;  352 2155-2157
• 36 Oxman M N, Levin M J, Johnson G R. et al . A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.  N Engl J Med. 2005;  352 2271-2284
• 37 Palliser D, Chowdhury D, Wang Q Y. et al . An si-RNA-based microbicide protects mice from lethal herpes simplex virus 2 infection.  Nature. 2006;  439 89-94
• 38 Reisinger E C, Fritzsche C, Krause R, Krejs G J. Diarrhea caused by primarily non-gastrointestinal infections.  Nature Clin Pract Gastroenterol Hepatol. 2005;  2 216-222
• 39 Reisinger E C, Gürtler L. Aviäre Influenza - eine weitere Zoonose.  Dtsch Med Wochenschr. 2006;  131 1279-1282
• 40 Reithinger R, Mohsen M, Wahid M. et al . Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.  Clin Infect Dis. 2005;  40 1148-1155
• 41 Shekhar K, Lye M S, Norlijah O. et al . Deaths in children during an outbreak of hand, foot and mouth disease in peninsular Malaysia - clinical and pathological characteristics.  Med J Malaysia. 2005;  60 297-304
• 42 Snow R W, Guerra C A, Noor A M, Myint H Y, Hay S I. The global distribution of clinical episodes of Plasmodium falciparum malaria.  Nature. 2005;  434 214-217
• 43 Steinbrook R. The potential of human papillomavirus vaccines.  N Engl J Med. 2006;  354 1109-1112
• 44 Süß J. Zunehmende Verbreitung der Frühsommer-Meningoenzephalitis in Europa.  Dtsch Med Wochenschr. 2005;  130 1397-1400
• 45 Süß J, Klaus C, Diller R, Schrader C, Wohanka N, Abel U. TBE incidence versus prevalence and increased prevalence of the TBE virus in Ixodes ricinus removed from humans.  Int J Med Microbiol. 2006;  296 (Suppl 1) 63-68
• 46 www.emea.eu.int/htms/human/epar/azepar.htm